Simmons, Lucy A. M. http://orcid.org/0000-0002-2112-6038
Kanthabalan, Abi
Arya, Manit
Briggs, Tim
Charman, Susan C.
Freeman, Alex
Gelister, James
Jameson, Charles
McCartan, Neil
Moore, Caroline M.
van der Muelen, Jan
Emberton, Mark
Ahmed, Hashim U.
Article History
Received: 28 April 2018
Revised: 19 July 2018
Accepted: 16 August 2018
First Online: 2 October 2018
Compliance with ethical standards
:
: ME’s research is supported by core funding from the NIHR UCH/UCL Biomedical Research Centre. He is an NIHR Senior Investigator. HUA receives funding from the Wellcome Trust, MRC and Prostate Cancer UK. HUA’s research is supported by core funding from the NIHR UCH/UCL Biomedical Research Centre. HUA receives funding from Sonacare Medical, Sophiris and Trod Medical for other trials. Travel allowance was previously provided from Sonacare Inc. He is a paid consultant to Sophiris for trial-related work. ME has stock interest in Nuada Medical Ltd. He is also a consultant to Steba Biotech and GSK. He receives travel funding from Sanofi Aventis, Astellas, GSK and Sonacare. He previously received trial funding or resources from GSK, Steba Biotech and Angiodynamics and currently receives funding for trials from Sonacare Inc, Sophiris Inc and Trod Medical. AF has stock interest in Nuada Medical Ltd. All the other authors declare no conflict of interest.